Bladder Cancer

Treatment Rechallenge with Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma - Beyond the Abstract January 25, 2023

Impact of the Controlling Nutritional Status (CONUT) Score on Perioperative Morbidity and Oncological Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy - Beyond the Abstract January 19, 2023

Non-Urothelial and Urothelial Variants of Bladder Cancer - Beyond the Abstract January 10, 2023

An Efficient Framework for Video Documentation of Bladder Lesions for Cystoscopy: A Proof-of-Concept Study - Beyond the Abstract November 29, 2022

Targeting the FGFR Pathway in Urothelial Carcinoma: The Future is Now - Beyond the Abstract November 22, 2022

Non-Muscle-Invasive Bladder Cancer: An Overview of Potential New Treatment Options - Beyond the Abstract November 17, 2022

A Hypothesis-Generating Analysis on the Role of TERT Promoter Mutation in Advanced Urothelial Carcinoma Treated with Immunotherapy - Beyond the Abstract November 3, 2022

International Consensus Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy: Update From an IBIS Workgroup - Beyond the Abstract November 2, 2022

Novel Intravesical Bacterial Immunotherapy Induces Rejection of BCG-Unresponsive Established Bladder Tumors - Beyond the Abstract October 10, 2022

Immune Mechanisms and Molecular Therapeutic Strategies to Enhance Immunotherapy in Non-Muscle Invasive Bladder Cancer - Beyond the Abstract September 20, 2022

Phase II Trial of CV301 Vaccine Combined with Atezolizumab in Advanced Urothelial Carcinoma - Beyond the Abstract September 7, 2022

Machine Learning Decision Support Model for Radical Cystectomy Discharge Planning - Beyond the Abstract August 30, 2022

En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Non inferiority Trial - Beyond the Abstract August 3, 2022

C-Reactive Protein Flare Predicts Response to Anti-PD-(L)1 Immune Checkpoint Blockade in Metastatic Urothelial Carcinoma - Beyond the Abstract July 27, 2022

Treatment Trends for Muscle-Invasive Bladder Cancer in Germany from 2006 to 2019 - Beyond the Abstract July 26, 2022

The Learning Curve in Bladder MRI Using VI-RADS Assessment Score During an Interactive Dedicated Training Program - Beyond the Abstract July 20, 2022

Systemic Therapy Issues: Immunotherapy in Nonmetastatic Urothelial Cancer - Beyond the Abstract July 19, 2022

What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract July 12, 2022

Adjuvant Chemotherapy Versus Observation Following Radical Cystectomy for Locally Advanced Urothelial Carcinoma of the Bladder - Beyond the Abstract June 30, 2022

Combined miRNA and SERS Urine Liquid Biopsy for the Point-of-Care Diagnosis and Molecular Stratification of Bladder Cancer - Beyond the Abstract June 23, 2022

Page 1 of 20

email news signup